P38 MAP kinase inhibitors
摘要:
There are provided inter alia compounds of formula (I) wherein R1, Ar, L, X, R3 and Q are as defined in the specification for use in therapy, especially in the treatment of inflammatory diseases.
公开/授权文献
信息查询
0/0